CVS

CVS Caremark’s Price Target Boosted at Goldman Sachs (CVS)

An image of a few devices next to a stock chart Credit: Shutterstock photo

Drugstore chain operator CVS Caremark Corporation ( CVS ) on Thursday saw its price target raised by analysts at Goldman Sachs.

The firm maintained its "Buy" rating while lifting its price target to $44. That new target suggests a 9% upside to the stock's Wednesday closing price of $40.46.

Goldman noted that the company's increased credibility had provided new confidence in its future growth prospects.

CVS Caremark shares were mostly flat in premarket trading Thursday.

The Bottom Line

Shares of CVS Caremark ( CVS ) have a 1.61% dividend yield, based on last night's closing stock price of $40.46. The stock has technical support in the $37 price area. The stock is approaching all-time high levels of $43 a share.

CVS Caremark Corporation ( CVS ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.3 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Created by Dividend.com


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.